Comparison of the effect of enoxaparin and UFH in pregnant patients with metallic heart valve at first trimester of pregnancy
Phase 3
Recruiting
- Conditions
- Pregnancy Outcome in Women with Mechanical Prosthetic Heart Valves.
- Registration Number
- IRCT20171030037093N28
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 34
Inclusion Criteria
No drug allergy to any of the drugs studied
No history of recurrent miscarriage or stillbirth associated with antiphospholipid syndrome
Being monitored by the researcher from the beginning of pregnancy
Having Class I or II heart disease
Having a metal heart valve
Having a pregnancy week of 14 weeks or less
Exclusion Criteria
Non-cooperation after inclusion
Lack of access to the patient and follow-up
Forced to terminate pregnancy immediately
Warfarin use in the first 3 months
Patients not able to follow up anti-10a factor
Thrombocytopenia (less than 75,000)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maternal complications. Timepoint: After intervention. Method of measurement: Check list.;Fetal complications. Timepoint: After intervention. Method of measurement: Check list.
- Secondary Outcome Measures
Name Time Method